Associated Papers
Structural basis for the activity and specificity of the immune checkpoint inhibitor lirilumab.
Lorig-Roach N et al.
Scientific Reports, 2024
38185735 (PubMed )
Supplement: 41598_2023_50262_MOESM1_ESM.pdf
Select a paper to view details